Small Business News Watch
SEE OTHER BRANDS

Global take on small business news

Small Business News Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Small Business News Watch.

Press releases published on April 3, 2025

Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution

Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution

TORONTO, April 03, 2025 (GLOBE NEWSWIRE) -- (TSX: SPFD) Mulvihill Enhanced Split Preferred Share ETF has declared a monthly cash distribution in the amount of $0.08333 per unit, payable on May 7, 2025 to unitholders of record on April 30, 2025. For further …

Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class

Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class

TORONTO, April 03, 2025 (GLOBE NEWSWIRE) -- (TSX: MPY) Mulvihill Premium Yield Fund has declared a monthly cash distribution for its ETF Class in the amount of $0.06400 per unit, payable on May 7, 2025 to unitholders of record on April 30, 2025. For …

Premium Global Income Split Corp. Declares Monthly Distribution

Premium Global Income Split Corp. Declares Monthly Distribution

TORONTO, April 03, 2025 (GLOBE NEWSWIRE) -- (TSX: PGIC; PGIC.PR.A) Premium Global Income Split Corp. has declared monthly distributions payable on April 30, 2025 to shareholders of record on April 15, 2025 in the following amounts per share: Share Class …

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., April 03, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on April 1, 2025, it awarded …

I-Mab Reports Full Year 2024 Financial Results and Provides Business Update

I-Mab Reports Full Year 2024 Financial Results and Provides Business Update

Continued positive momentum in givastomig Phase 1b combination trial in first-line gastric cancer, with topline dose escalation data (n=17) expected in 2H 2025 Enrollment completed ahead of schedule in the first givastomig Phase 1b dose expansion cohort; …

اختتم مهرجان فن رأس الخيمة 2025 بنجاح باهر، ممهدًا الطريق لملتقى "الحضارات" في عام 2026

اختتم مهرجان فن رأس الخيمة 2025 بنجاح باهر، ممهدًا الطريق لملتقى "الحضارات" في عام 2026

RAS AL KHAIMAH, UNITED ARAB EMIRATES, April 3, 2025 /⁨EINPresswire.com⁩/ -- - اختتم مهرجان فن رأس الخيمة 2025 فعالياته بنجاح باهر، مؤكداً مكانته كمنصة ثقافية وفنية رائدة في المنطقة. وبحضورٍ حافل تجاوز 39,000 زائر، عرض المهرجان مجموعةً فنيةً رائعة تضم 190 …

Obiettivi più grandi, budget più piccoli: Il 73% dei marketer fatica con meno risorse, nonostante il ricorso all'IA

Obiettivi più grandi, budget più piccoli: Il 73% dei marketer fatica con meno risorse, nonostante il ricorso all'IA

ROME, ITALY, April 3, 2025 /⁨EINPresswire.com⁩/ -- Una nuova ricerca di SALESmanago, una delle piattaforme di Customer Engagement leader in Europa con oltre 3.000 clienti, ha rilevato che ai marketer europei viene chiesto di ottenere di più con meno, dato …

OpenPayd's Barry O'Sullivan Illuminates Embedded Finance at PAY360 2025

OpenPayd's Barry O'Sullivan Illuminates Embedded Finance at PAY360 2025

At the PAY360 2025 conference, Barry O'Sullivan, Head of Banking and Payments Infrastructure at OpenPayd, shared his insights on embedded finance. LONDON, UNITED KINGDOM, April 3, 2025 /⁨EINPresswire.com⁩/ -- At the PAY360 2025 conference, held on March …

PEPITEM sequence shows effects in psoriasis, comparable to steroid cream

PEPITEM sequence shows effects in psoriasis, comparable to steroid cream

A sequence of just three amino acids from the PEPITEM molecule may reduce the severity of psoriasis, when applied topically in an emollient cream. BIRMINGHAM, WEST MIDLANDS, UNITED KINGDOM, April 3, 2025 /⁨EINPresswire.com⁩/ -- Scientists from the …

MU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Micron Technology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

MU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Micron Technology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

GERN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GERN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--(PR NEWSWIRE)--Bronstein, Gewirtz …

TTD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that The Trade Desk, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

TTD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that The Trade Desk, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

EIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edison International Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

EIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edison International Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized …

Moomoo and the NY Mets Announce Strategic Partnership to Elevate Fans Experience to the Next Level

Moomoo and the NY Mets Announce Strategic Partnership to Elevate Fans Experience to the Next Level

JERSEY CITY, N.J., April 03, 2025 (GLOBE NEWSWIRE) -- Moomoo, a global investment and trading platform, is proud to announce a groundbreaking partnership with the New York Mets in a multiyear multimillion-dollar sponsorship. This collaboration is set to …

ARB IOT Group Limited Introduces AI Drone Technology to Revolutionise Plantation Management

ARB IOT Group Limited Introduces AI Drone Technology to Revolutionise Plantation Management

Kuala Lumpur, Malaysia, April 03, 2025 (GLOBE NEWSWIRE) -- ARB IOT Group Limited (“ARB IOT” or the “Company”) (NASDAQ: ARBB) has introduced its advanced AI-powered plantation mapping system which is seamlessly integrated with drone technology (“Smart AI …

CabinetryNews.com: President Trump Signs Reciprocal Tariffs Executive Orders That Will Impact The Cabinetry Industry

CabinetryNews.com: President Trump Signs Reciprocal Tariffs Executive Orders That Will Impact The Cabinetry Industry

Trump signs sweeping reciprocal tariffs order, impacting 60+ countries and key industries, including the top 4 countries manufacturing for the cabinetry sector. NASDAQ (NASDAQ:INDEXNASDAQ: .IXIC) WASHINGTON, DC, UNITED STATES, April 3, 2025 /⁨ …

Neumora Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. April 7, 2025 Deadline to file Lead Plaintiff Motion.

Neumora Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. April 7, 2025 Deadline to file Lead Plaintiff Motion.

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 03, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Neumora Therapeutics, Inc. ("Neumora" or the "Company") (NASDAQ: NMRA) investors of a …

Partenaires Ninepoint annonce la deuxième clôture de Ninepoint 2025 Flow-Through Limited Partnership

Partenaires Ninepoint annonce la deuxième clôture de Ninepoint 2025 Flow-Through Limited Partnership

TORONTO, 03 avr. 2025 (GLOBE NEWSWIRE) -- Partenaires Ninepoint LP (« Ninepoint ») est heureuse d’annoncer que Ninepoint 2025 Flow-Through Limited Partnership (la « société en commandite ») a mené à bien la deuxième clôture dans le cadre de son placement …

Ninepoint Partners Announces Second Closing of Ninepoint 2025 Flow-Through Limited Partnership

Ninepoint Partners Announces Second Closing of Ninepoint 2025 Flow-Through Limited Partnership

TORONTO, April 03, 2025 (GLOBE NEWSWIRE) -- Ninepoint Partners LP (“Ninepoint”) is pleased to announce that the Ninepoint 2025 Flow-Through Limited Partnership (the “Partnership”) has completed the second closing in connection with its offering of Class A …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service